Laboratory sciences: Laboratory issues and testing | Virtual Summit 2020


Year: 2020

Language: English

Author(s): World Federation of Hemophilia

View Online
Additional Information

In this session from the WFH 2020 Virtual Summit, Steve Kitchen, Stefen Tiefenbacher, Anna Lowe and Annette Bowyer discuss:

  • Gene therapy for FVIII and FIX: Will there be laboratory assay issues?
  • Laboratory issues with isolated emicizumab therapy
  • Laboratory issues when emicizumab and FVIII replacement are combined


The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.